Table 2.
Glycemic ranges (%time) | Median %time (IQR) |
Kruskal–Wallis (P-value) | ||
---|---|---|---|---|
rtCGM | SMBG (carry forward method) | SMBG (linear interpolated) | ||
TIR | ||||
3.9–10 mmol/L (70–180 mg/dL) | 63.0 (55.9–71.0) | 54.6 (45.3–63.0) | 61.4 (50.1–69.5) | <0.001a–c |
TBR | ||||
<3.9 mmol/L (70 mg/dL) | 3.5 (1.8–5.1) | 3.9 (2.0–6.3) | 1.6 (0.8–3.3) | <0.001a–c |
<3.0 mmol/L (54 mg/dL) | 0.8 (0.3–1.3) | 0.7 (0.3–1.5) | 0.4 (0.1–0.6) | <0.001b,c |
TAR | ||||
>10 mmol/L (180 mg/dL) | 33.4 (25.1–41.3) | 40.1 (31.6–51.3) | 35.6 (26.5–48.2) | <0.001a–c |
>15 mmol/L (270 mg/dL) | 5.0 (2.7–8.2) | 8.6 (4.5–13.3) | 4.5 (2.0–8.7) | <0.001a,b,d |
Significant difference between rtCGM and SMBG carry forward method (P < 0.001).
Significant difference between SMBG using linear interpolation and carry forward method (P < 0.001).
Significant difference between SMBG using linear interpolation and rtCGM (P < 0.001).
Significant difference between SMBG using linear interpolation and rtCGM for TAR >15 mmol/L; >270 mg/dL (P = 0.01).
TAR, time above range; TBR, time below range; TIR, time in range.